Background Percutaneous closure of a patent foramen ovale (PFO) or the left atrial
appendage (LAA) are controversial procedures to prevent stroke but often used in clinical …

Introduction Patent foramen ovale closure reduces recurrence of cryptogenic ischaemic
stroke compared to anti-platelet therapy. Our goal was to determine procedure volumes and …

Foramen ovale is one of the essential shunts of the fetal blood flow allowing oxygenated
blood to enter the systemic circulation. At birth, as the lungs expand, and oxygen fills the …

Objectives Although sex differences have been emphasized in stroke and congenital heart
disease, there has been limited investigation into their role in patent foramen ovale (PFO) …

Background: Randomized-controlled trials (RCTs) reported a finding on the safety and
efficacy of percutaneous patent foramen ovale (PFO) closure to prevent stroke recurrence. It …

Stroke is a major contributor to population morbidity and mortality. Cardiac thromboembolic
sources are an important potential cause of stroke. Left atrial appendage (LAA) …

Background A patent foramen ovale (PFO) is formed when the ovale foramen does not close
spontaneously or re-opens leaving the right and left atrium connected. The present study …

Objectives To evaluate the impact of National Institute for Health and Care Excellence
(NICE) guidance in January 2005 and subsequent trial evidence on the adoption of …

Background Transcatheter closure of patent foramen ovale (PFO) has reduced the risk of
recurrent stroke in patients with cryptogenic strokes in randomized clinical trials. Whether …

Introduction: The predictors and national readmissions rates after Patent Foramen Ovale
closure (PFO) post cryptogenic stroke is not well studied. Hypothesis: We sought to evaluate …